Melanoma
Steven A. Rosenberg, MD, PhD
National Cancer Institute
Father of Immunotherapy
- Pioneered the use of adoptive immunotherapy.
- Chief of Surgery at the National Cancer Institute.
- Credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer.
- Has shown that expanding immune cells (known as tumor infiltrating lymphocytes) in the lab can be used to treat patients with melanoma.
